Evidence map›Paper›PMID 36333671›Full record

ArticleBMC pregnancy and childbirth2022

Prediction model of gonadotropin starting dose and its clinical application in controlled ovarian stimulation.

Liang Hua, Yang Zhe, Yang Jing, Shen Fujin, Chen Jiao, Liu Liu

Abstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Observational
  3. Review
  4. Clinical data-based modeling of IVF live birth outcome and its application.Reproductive biology and endocrinology : RB&E · 2024
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Liang Hua *Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.
Yang Zhe *Reproductive Medicine Center, Renmin Hospital of Wuhan University, Wuhan, China.
Yang JingReproductive Medicine Center, Renmin Hospital of Wuhan University, Wuhan, China.
Shen FujinDepartment of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.
Chen JiaoReproductive Medicine Center, Renmin Hospital of Wuhan University, Wuhan, China.
Liu LiuDepartment of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China. drliuliu@whu.edu.cn.

Funding

National Natural Science Foundation of China 82001642
6 · The paper itself

Abstract

backgroundSelecting an appropriate and personalized Gn starting dose (GSD) is an essential procedure for determining the quality and quantity of oocytes in the controlled ovarian stimulation (COS) process of the in-vitro fertilization (IVF) treatment cycle. The current approach for determining the GSD is mainly based on the experience of a clinician, lacking unified and scientific standards. This study aims to establish a prediction model of GSD, based on which good COS outcomes can be achieved with the influencing factors comprehensively evaluated quantitatively. MATERIAL AND

methodsWe collected a total of 1555 patients undergoing the first oocytes retrieving cycle and conducted correlation analysis to find the significant factors related to the GSD. Two GSD models are built based on two popular machine learning approaches, and the one with better model performance is selected as the final model. Finally, clinical application and validation were conducted to verify the effectiveness of the proposed model.

results(1) Age, duration of infertility, type of infertility, body mass index (BMI), antral follicle count (AFC), basal follicle stimulating hormone (bFSH), estradiol (E

conclusionModeling the GSD value with machine learning approaches is feasible and effective, and the proposed model has good clinical application for determining the GSD in the IVF treatment cycle.

Indexed as

InfertilityOvulation InductionAnti-Mullerian HormoneFemaleFertilization in VitroFollicle Stimulating HormoneHumansOvarian FollicleAnti-Mullerian HormoneFollicle Stimulating HormoneControlled ovarian stimulationGn starting doseIn-vitro fertilizationMachine learning

Identifiers

PMID36333671
PMCPMC9635211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.